Jing Jing Wang was awarded an Australian Endeavour International Postgraduate Research Scholarship to undertake a PhD in the Medical Biotechnology Department at Flinders University. She received considerable recognition for her scholarship, receiving several awards at state and national levels. Following her PhD awarded in December 2012, she joined Prof. Tom Gordon’s research team in the Department of Immunology, Flinders University. This key move introduced her to translational research in clinical immunology, in particular the emerging field of proteomic autoantibody technology. She received an NHMRC Peter Doherty Early Career Fellow from 2015 to 2019 and is currently DVCR Research Fellow with a research focus on mass spectrometric (MS) sequencing of human antibody repertoires and the related bioinformatics. She is particularly interested in systemic autoimmune diseases (SADs; including lupus, Sjögren’s syndrome, and rheumatoid arthritis) and infectious diseases (HBV/HCV, influenza and clostridium difficile). She is also working on sequencing high affinity SARS-CoV-2 antibodies collaborating with the Doherty Institute. A key goal is to address the diagnosis delay and lack of specific therapies for these diseases that hinder effective management of these patients by identifying potential biomarkers and novel disease mechanisms for therapeutic interventions. She has a good track record in autoantibody and autoimmune diseases for high-impact publications in journals such as Cell, Annals of Rheumatic Diseases, and Arthritis & Rheumatology.